A generic drug and a biosimilar drug are both types of drugs that are intended to be less expensive alternatives to brand-name drugs, but they are produced using different manufacturing processes. A generic drug is a copy of a brand-name drug that is made after the original patent has expired. Generic drugs are identical in […]
Monthly Archives: April 2023
11
Apr
Apr
The life science market is a vast and rapidly evolving industry that encompasses a wide range of products and services related to healthcare, biotechnology, and medical research. It includes companies involved in the development and manufacturing of pharmaceuticals, medical devices, diagnostics, and research tools, as well as contract research organizations, healthcare providers, and academic and […]
10
Apr
Apr
It is safe to say that a significant proportion of biologics in development are being developed as injectable drugs. Many biologics are large, complex molecules that cannot be absorbed effectively through the digestive tract, which means that they must be delivered via injection to be effective. This is particularly true for biologics used to treat […]
07
Apr
Apr
As of 2021, there are more biologics in clinical trials compared to small molecules. According to a report by the Pharmaceutical Research and Manufacturers of America (PhRMA), in 2020, there were 6,895 biologics in clinical trials, compared to 3,819 small molecules. Trend moving towards biologics The trend of increasing clinical trials for biologics has been […]
06
Apr
Apr
The pharmaceutical market is a complex and dynamic industry that is constantly evolving. It is characterized by a wide range of stakeholders, including pharmaceutical companies, healthcare providers, patients, regulators, and payers, all of whom have different interests and priorities. Understanding the characteristics of the pharmaceutical market is essential for companies operating in this sector to […]
05
Apr
Apr
The manufacturing process for biologic drugs is complex and involves several steps. Here’s a general overview of the process: It’s important to note that the manufacturing process for biologic drugs is highly regulated by government agencies, such as the U.S. Food and Drug Administration (FDA), to ensure the safety, efficacy, and quality of the final […]
05
Apr
Apr
The primary difference between small and large molecules is their molecular weight and size. Small molecules typically have a molecular weight of less than 900 daltons and consist of simple organic molecules that can be synthesized chemically. Large molecules, on the other hand, are much larger and more complex and are typically composed of biologically […]
04
Apr
Apr
The likelihood of a pharmaceutical drug coming to market is relatively low. Developing a new drug is a complex and expensive process that can take many years and involve significant investment. According to the Pharmaceutical Research and Manufacturers of America (PhRMA), the average cost of developing a new drug from discovery to approval is over […]
- 1
- 2